ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Bacterial sepsis,Bacterial infections NEC,Bacterial infectious disorders,Infec,Y
1,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
2,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
3,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
3,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
3,3,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
3,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
3,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
3,7,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
4,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
5,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
5,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
5,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
5,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
6,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
7,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
8,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
9,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
10,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
12,1,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
13,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
13,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
14,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
14,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
14,3,Hypothyroidism,Thyroid hypofunction disorders,Thyroid gland disorders,Endo,N
15,1,Neovascularisation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
16,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
16,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
16,3,Tension headache,Headaches NEC,Headaches,Nerv,N
17,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
17,2,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
17,3,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
18,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
21,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
22,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
22,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
22,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
22,4,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
22,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
23,1,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
23,2,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
24,1,Arteriosclerosis coronary artery,Coronary artery disorders NEC,Coronary artery disorders,Card,N
24,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
24,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
24,4,Pleural thickening,Pleural conditions NEC,Pleural disorders,Resp,N
25,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
25,2,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
25,3,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,Y
26,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
27,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
27,2,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
27,3,Retinal vascular occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
28,1,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
29,1,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
29,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
30,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
30,2,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
30,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
30,4,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
30,5,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
30,6,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
31,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
31,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
31,3,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
32,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
33,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
34,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
34,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
35,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
36,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
36,2,Pulmonary arterial hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
37,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
38,1,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
39,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
40,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
40,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
40,3,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
41,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
42,1,Acute lymphocytic leukaemia,Leukaemias acute lymphocytic,Leukaemias,Neopl,N
42,2,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
43,1,Miscarriage of partner,Family and partner issues,Family issues,SocCi,N
43,2,Pregnancy of partner,Family and partner issues,Family issues,SocCi,N
44,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
44,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
45,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
46,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
47,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
48,1,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
49,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
49,2,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
49,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
50,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
50,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
50,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
50,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
51,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
51,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
51,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
51,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
51,5,Ehlers-Danlos syndrome,Connective tissue disorders congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
51,6,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
51,7,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,8,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
52,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
52,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
53,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
53,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
53,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
53,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
54,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
54,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
54,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
55,1,Acute coronary syndrome,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
56,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
56,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
56,3,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
56,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
56,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
56,6,Migraine,Migraine headaches,Headaches,Nerv,N
56,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
56,8,Peripheral arterial occlusive disease,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
56,9,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
56,10,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
56,11,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
56,12,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
56,13,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
56,14,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
57,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
57,3,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
58,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
58,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
58,3,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
58,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
59,1,Foetal disorder,Foetal complications NEC,Foetal complications,Preg,N
59,2,Paternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
60,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
60,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
62,1,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
62,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
63,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
64,1,Blindness unilateral,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
64,2,Retinal artery occlusion,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
65,1,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
65,2,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
65,3,Coronary artery disease,Coronary artery disorders NEC,Coronary artery disorders,Card,N
65,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
65,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
65,6,Peripheral artery occlusion,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
65,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
65,8,Renal artery stenosis,Renal vascular and ischaemic conditions,Renal disorders (excl nephropathies),Renal,N
66,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
66,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
68,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
68,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
69,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
69,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
69,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
70,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,2,Blood bilirubin decreased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,3,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
70,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
70,5,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
70,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
71,1,Progressive multifocal leukoencephalopathy,Polyomavirus infections,Viral infectious disorders,Infec,N
72,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
72,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
73,1,Sarcoma of skin,Soft tissue sarcomas histology unspecified,Soft tissue neoplasms malignant and unspecified,Neopl,N
74,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
74,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
74,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
75,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
75,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
75,3,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
75,4,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
75,5,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
75,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
75,7,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,8,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
75,9,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
75,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
75,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
75,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
75,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
75,14,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
75,15,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
75,16,Shift to the left,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
75,17,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,18,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,19,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
76,1,Blood pH increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
76,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
76,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
76,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
76,6,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
77,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
77,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
78,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
78,2,Drug ineffective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
78,3,Hepatocellular carcinoma,Hepatic neoplasms malignant,Hepatobiliary neoplasms malignant and unspecified,Neopl,N
78,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
78,5,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
79,1,Clear cell renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
80,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
80,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
80,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,4,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
80,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
80,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
81,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
82,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
82,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
82,3,Myelosuppression,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
82,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
82,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
82,6,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
82,7,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
83,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
84,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
84,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
84,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
85,1,Clonal evolution,Oncologic complications and emergencies,Neoplasm related morbidities,Neopl,N
85,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,3,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
85,4,Peripheral vascular disorder,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
85,5,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
86,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
86,2,Loss of therapeutic response,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
87,1,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
88,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
88,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
88,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
89,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
90,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
90,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
91,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
91,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
92,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
93,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
93,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
94,1,Dermatitis psoriasiform,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
95,1,Chronic myeloid leukaemia,Leukaemias chronic myeloid,Leukaemias,Neopl,N
95,2,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
95,3,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,4,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,5,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
95,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
96,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
96,2,Pneumonia fungal,Fungal infections NEC,Fungal infectious disorders,Infec,N
97,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
97,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
97,3,Headache,Headaches NEC,Headaches,Nerv,N
98,1,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
98,3,Philadelphia chromosome positive,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
98,4,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
98,5,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
98,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
99,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
100,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
100,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
101,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
101,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
101,3,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,4,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
101,5,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
101,6,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
101,7,Appendicitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
101,8,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
101,9,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,10,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
101,11,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
101,12,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
101,13,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
101,14,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
101,15,Chronic myeloid leukaemia recurrent,Leukaemias chronic myeloid,Leukaemias,Neopl,N
101,16,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
101,17,Connective tissue disorder,Connective tissue disorders NEC,Connective tissue disorders (excl congenital),Musc,N
101,18,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
101,19,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
101,20,Death,Death and sudden death,Fatal outcomes,Genrl,Y
101,21,Dental caries,Dental and periodontal infections and inflammations,Dental and gingival conditions,Gastr,N
101,22,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
101,23,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
101,24,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
101,25,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
101,26,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
101,27,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
101,28,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
101,29,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
101,30,Graft versus host disease,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
101,31,Headache,Headaches NEC,Headaches,Nerv,N
101,32,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
101,33,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
101,34,Hypoalbuminaemia,Protein metabolism disorders NEC,Protein and amino acid metabolism disorders NEC,Metab,N
101,35,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
101,36,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
101,37,Hypomagnesaemia,Magnesium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
101,38,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
101,39,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
101,40,Ill-defined disorder,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,41,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
101,42,Infestation,Ectoparasitic infestations,Ectoparasitic disorders,Infec,N
101,43,Investigation abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
101,44,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
101,45,Leukocytosis,Leukocytoses NEC,White blood cell disorders,Blood,N
101,46,Lymphatic disorder,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
101,47,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
101,48,Malnutrition,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
101,49,Mediastinal disorder,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
101,50,Metabolic disorder,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
101,51,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,N
101,52,Musculoskeletal disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
101,53,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,54,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
101,55,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
101,56,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
101,57,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
101,58,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
101,59,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
101,60,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
101,61,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
101,62,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
101,63,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
101,64,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
101,65,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
101,66,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
101,67,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,68,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,69,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
101,70,Transplantation complication,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
101,71,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
101,72,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
101,73,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
102,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
102,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
102,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
103,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,2,Drug resistance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
103,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
104,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
105,1,Leukaemia recurrent,Leukaemias NEC,Leukaemias,Neopl,N
106,1,Cardiovascular disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
106,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
107,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
107,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
107,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
107,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
107,5,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
107,6,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
107,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
108,1,Choroidal effusion,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
108,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
108,3,Uveitis,"Iris and uveal tract infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
109,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
109,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
109,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
109,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
110,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
111,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
111,2,Muscle disorder,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
111,3,Myopathy toxic,Myopathies,Muscle disorders,Musc,N
112,1,Cytogenetic analysis abnormal,Chromosome analyses,Cytogenetic investigations and genetic analyses,Inv,N
112,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
113,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
114,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
114,2,Neutrophil count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
115,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
116,1,Thyroiditis,Acute and chronic thyroiditis,Thyroid gland disorders,Endo,N
117,1,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
117,2,Headache,Headaches NEC,Headaches,Nerv,N
117,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
117,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
117,5,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
117,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
118,1,Amylase increased,Digestive enzymes,Gastrointestinal investigations,Inv,N
118,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
118,3,Haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
118,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
118,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
118,6,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
119,1,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
120,1,Arnold-Chiari malformation,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
120,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
120,3,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
121,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
122,1,Arnold-Chiari malformation,Cerebellar disorders congenital,Neurological disorders congenital,Cong,N
122,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
123,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
123,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
124,1,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
124,2,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
125,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
126,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
127,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
128,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
128,2,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
129,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
130,1,Atrial flutter,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
131,1,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
132,1,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
133,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
133,2,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
134,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
135,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
136,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
136,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
137,1,Acne,Acnes,Skin appendage conditions,Skin,N
137,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
137,3,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
137,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
137,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
137,6,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
137,7,White blood cell count abnormal,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
138,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
